Amnon Peled

Jerusalem, JM 91121, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications

Entinostat Enhances Antigen-Specific CD8 T-Cell Response to Immunotherapies in Lung Cancer Models.

Entinostat Enhances Antigen-Specific CD8 T-Cell Response to Immunotherapies in Lung Cancer Models.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 31, 2026

MiR-122 regulates liver tolerance.

MiR-122 regulates liver tolerance.

Journal: JHEP reports : innovation in hepatology
Published: March 18, 2026

Irinotecan Modulates Immune Checkpoints in Neuroblastoma.

Irinotecan Modulates Immune Checkpoints in Neuroblastoma.

Journal: ImmunoTargets and therapy
Published: January 25, 2026

BKT300: A Novel Anti-Leukemic Small Molecule Targeting the Protein Regulator of Cytokinesis 1 (PRC1) Pathway.

BKT300: A Novel Anti-Leukemic Small Molecule Targeting the Protein Regulator of Cytokinesis 1 (PRC1) Pathway.

Journal: Research square
Published: March 04, 2025

DSP502 Combines Dual Inhibition of PD-L1 and PVR to Trigger Anticancer Immune Responses.

DSP502 Combines Dual Inhibition of PD-L1 and PVR to Trigger Anticancer Immune Responses.

Journal: Molecular cancer therapeutics
Published: January 25, 2025

Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1.

Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1.

Journal: Frontiers in immunology
Published: September 26, 2024

Targeting CCL24 in Inflammatory and Fibrotic Diseases: Rationale and Results from Three CM-101 Phase 1 Studies.

Targeting CCL24 in Inflammatory and Fibrotic Diseases: Rationale and Results from Three CM-101 Phase 1 Studies.

Journal: Drug safety
Published: April 17, 2024

The Role of CCL24 in Primary Sclerosing Cholangitis: Bridging Patient Serum Proteomics to Preclinical Data.

The Role of CCL24 in Primary Sclerosing Cholangitis: Bridging Patient Serum Proteomics to Preclinical Data.

Journal: Cells
Published: December 19, 2023

CDC25C Protein Expression Correlates with Tumor Differentiation and Clinical Outcomes in Lung Adenocarcinoma.

CDC25C Protein Expression Correlates with Tumor Differentiation and Clinical Outcomes in Lung Adenocarcinoma.

Journal: Biomedicines
Published: December 13, 2022

Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signaling.

Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signaling.

Journal: Journal of hepatology
Published: June 16, 2022

CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression.

CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression.

Journal: Journal of hematology & oncology
Published: June 06, 2022

CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis.

CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis.

Journal: JCI insight
Published: May 31, 2022
Showing 1-12 of 54

Last Updated: 09/26/2026